Collateral flow channel sealant delivery methods and systems
Inventors
Radhakrishnan, Sri • Olivera, Ryan
Assignees
Interested in licensing this patent?
MTEC can help explore whether this patent might be available for licensing for your application.
Abstract
Devices, methods, and systems are provided for occluding a collateral flow channel between a target lung compartment and an adjacent lung compartment. A video-assisted thoracoscopic device is inserted into a thoracic cavity of a patient and positioned at a fissure between a target lung compartment and an adjacent lung compartment. A collateral flow channel between the target lung compartment and the adjacent lung compartment is then identified using the video-assisted thoracoscopic device and an agent is injected into the collateral flow channel, thereby reducing the collateral flow channel.
Core Innovation
The disclosed subject matter relates to methods for occluding a collateral flow channel between a target lung compartment and an adjacent lung compartment. The disclosed approaches center on disrupting or reducing the channel, or closing tissue at the channel; [procedural detail omitted for safety]. The methods also encompass identifying the channel and assessing closure through pressure or flow measurements.
The provided disclosure further details deploying an endobronchial one-way valve associated with the target lung compartment, which allows exhalation while preventing inhalation to support target-region volume reduction. The subject matter therefore encompasses collateral flow channel occlusion and, in certain embodiments, cooperative endobronchial one-way airflow control; [procedural detail omitted for safety].
Claims Coverage
The claims identify three inventive features across three independent claims directed to occluding a collateral flow channel between a target lung compartment and an adjacent lung compartment.
Disruption of the collateral flow channel
Independent claim 1 covers disrupting tissue at the collateral flow channel using a cutting device; [procedural detail omitted for safety].
Reduction of the collateral flow channel using an agent
Independent claim 6 covers reducing the collateral flow channel through use of an agent; [procedural detail omitted for safety].
Closure of tissue at the collateral flow channel
Independent claim 15 covers disrupting the collateral flow channel by closing tissue with a closing device; [procedural detail omitted for safety].
The three independent claims address channel occlusion through tissue disruption, agent-based reduction, or mechanical tissue closure, with dependent claims addressing channel identification, closure or agent options, and endobronchial one-way airflow control.
Stated Advantages
The endobronchial one-way valve allows exhalation while preventing inhalation to support target-region volume reduction.
Documented Applications
Occlusion of a collateral flow channel between a target lung compartment and an adjacent lung compartment.
Use of an endobronchial one-way valve to support target-region volume reduction.
Interested in licensing this patent?